HIF1A and central nervous system cancer: In vitro studies demonstrated that down‐regulation of HIF1A‐AS2 led to delayed growth of mesenchymal GSC tumours, survival benefits and impaired expression of HMGA1, a target gene of this lncRNA, also was overexpressed in glioma.69, 70